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1. Introduction 
According to Beme’s hypothesis on the metabolic 
regulation of coronary blood flow, adenosine is the 
main vasoactive substance released from the myocar- 
dial cell during hypoxia [l] . The dilatory effect of 
exogenous adenosine on the coronary vessels is short- 
lived, due to its rapid inactivation in the blood and/or 
tissues. Using a new and fully automatic calorimetric 
method for the continuous determination of adenosine 
[2], we have found marked qualitative and quantitative 
differences in the rate of disappearance of adenosine 
from human and canine blood. The present paper re- 
ports on these differences, and shows that although in 
human blood adenosine is mainly taken up by the 
erythrocytes, in canine blood it is mainly taken up by 
the platelets. 
2. Materials and methods 
Approximately 8 ml of blood from healthy male 
human volunteers or from male beagle dogs was col- 
lected by free flow from a venipuncture into a plastic 
tube containing 2 ml of ACD (acid-citrate-dextrose: 
USP XVI, 662). All manipulations were performed 
using plastic syringes or tubes, and care was taken to 
avoid haemolysis. 
2.1. Preparation of total blood samples 
0.1 ml of human blood or 2 ml of canine blood was 
diluted to 8 ml with isotonic phosphate buffer 
(pH 7.4). 
2.2. Preparation of erythrocyte samples 
Total blood samples were centrifuged for 15 min 
at 350 g to separate the erythrocytes and the platelet- 
rich plasma. The sedimented red cells were then 
diluted with physiological saline at pH 7.4, and appro- 
ximately 8 ml was layered onto 25% Ficoll (Pharma- 
cia, Uppsala) in saline. The erythrocytes were separated 
from the residual platelets either by allowing the mix- 
ture to stand for several hours or by centrifuging at 
low speed. The erythrocytes thus obtained were 
washed twice with saline, taken up in 3 ml of saline, 
and aliquots of 0.1 ml (human) or 1 ml (canine) of 
the suspension were diluted to 8 ml with isotonic 
phosphate buffer. 
2.3. Preparation of plasma samples 
The platelet-rich plasma was centrifuged for 25 
min at 750 g to sediment most of the platelets, and 
a further 20 min at 2500 g to remove the remainder: 
2 ml of the supernatant was then added to 6 ml of 
phosphate buffer. 
2.4. Preparation of platelet samples 
The platelet sediment was washed 3 times with 
physiological saline by sucking up and down in a 
syringe and centrifuging. Aliquots of 1 ml (human) or 
0.5 ml (canine) of a suspension of the residue in 3 ml 
of saline were diluted to 8 ml. 
2.5. Beparation of lysates of total blood, evthrocytes 
and platelets 
Portions of the total blood, washed erythrocytes 
or platelets were diluted with water (1:4, v/v) and 
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sonicated for 2 X 1 min in ice-water using a Kerry 
Ultrasonicator at maximum power. For the human 
samples, aliquots comprising 0.5 ml of total blood 
lysate, 0.5 ml of erythrocyte lysate or 2 ml of platelet 
lysate were diluted to 8 ml with isotonic phosphate 
buffer. For the dog samples, 0.2 ml, 2 ml and 0.4 ml 
aliquots of the respective lysates were diluted to 8 ml. 
Each 8 ml fraction in turn was incubated at 37’C, 
agitated with a slow speed magnetic stirrer and taken 
up continuously for analysis at a rate of 0.23 ml/min. 
After exactly 5 min, to permit baseline establishment, 
0.787 pmoles of adenosine (= 300 ~1 of a solution 
containing 7 mg of adenosine/lO rnI of phosphate 
buffer) was added to the incubation mixture, to give 
a final adenosine concentration of 110 /.&I. The amount 
of adenosine in the mixture was followed continuously, 
using the technique described in an earlier publication 
PI. 
Erythrocytes, leucocytes and platelets were counted 
using a Fisher Autocytometer, except for the residual 
platelets in the erythrocyte suspension which were 
counted by direct microscopic examination. 
3. Calculation procedure 
The calculation procedure is illustrated in fig. 1. 
The heavy line ABC represents the (hypothetical) 
original trace; AB is the baseline and B the point at 
which 0.787 pmoles of adenosine were added to the 
incubation mixture. The narrow lines in the figure re- 
present stages in the calculation. A straight line DE is 
E 
0 
C 
0 
Fig. 1. Illustration of the technique used to calculate the rate 
of inactivation of adenosine by various blood fractions. For 
explanation, see Calculation Procedure in text. 
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drawn through the linear middle portion of the record. 
Extrapolation to zero time (i.e. the moment at which 
adenosine was added) gives the peak height F corres- 
ponding to the presence of 0.787 fimoles of adenosine. 
The time for 50% disappearance of adenosine can 
readily be determined by projection of the horizon- 
tals GH and IJ corresponding to 25% and 75% of the 
maximum peak height F: the time necessary to achieve 
a reduction (50%) in the peak height from J to H, and 
hence the time needed for inactivation of 0.394 pmoles 
of adenosine (5% of the 0.787 pmoles added) by the 
blood fraction in the incubate, corresponds to the time 
taken for the recorder pen to travel from J to H. (It is 
known that the reaction obeys Beer’s law for adenosine 
concentrations between 20 and 100 PM [2], and it is 
assumed that the uptake of adenosine during the 
time interval between J and H proceeds at a constant 
velocity.) The uptake of adenosine is expressed in 
pmoles/hr/ml of blood fraction in the final incubate. 
4. Results and discussion 
The results obtained using blood samples from 3 
humans and 3 dogs are summarized in tables 1-3. One 
determination of the rate of inactivation of adenosine 
by total blood (intact or lysed) was made for each of 
the 6 samples; all other determinations were performed 
on aliquots drawn from a pool of equal volumes of the 
3 human or canine blood samples. 
4.1. Total blood 
Table 2 shows that the rate of inactivation of ade- 
nosine by total human blood was about 10 times 
greater than that by canine blood. Our results are fully 
compatible with those reported for other studies on 
human [3,4] and canine [4,6] blood. 
Table 1 
Mean haematocrit and differential count for human and 
canine blood. 
Parameter Units Human blood Canine blood 
Haematocrit % 53.5 52 
Erythrocytes 109/cm3 4.4 6.1 
Platelets 108/cm3 2.75 3.30 
Leucocytes 106/cm3 6.6 9.7 
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Table 2 
Rate of inactivation of adenosine by human and canine blood and blood fractions at pH 7.4 and 37OC. 
Fraction 
Rate of adenosine inactivation by stated 
fraction (wmoles/hr) 
Intact blood Lysed blood 
Ratio of 
lysedlintact 
blood 
1 ml of total blood 
10’ erythrocytes 
Erithrocytes/ml of total blood* 
10 platelets 
Platelets/ml of total blood* 
1 ml of plasma 
Plasma/ml of total blood 
Human Canine 
10.5 f. 0.9 1.04 f 0.16 
Human 
11.4 f 0.8 
Canine 
18.4 + 1.6 
2.23 0.07 
9.81 0.43 
0 0.39 
0 1.29 
0.20 0.29 
0.11 0.15 
* Calculated from the results given in table 1. 
Table 3 
Relative potencies of the various blood fractions as adenosine 
inactivators (total blood = 100). 
Intact blood Lysed blood 
Fraction 
Human Canine Human Canine 
Total blood 100 100 100 100 
Erythrocytes 93.5 41.3 90.4 13.3 
Platelets 0 124 0 87.3 
Plasma 1.0 14.4 1.0 0.8 
Calculated from the results given in table 2. 
Haemolysis did not appreciably alter the rate of 
adenosine inactivation by total human blood (table 2). 
This finding is in agreement with those of Bunag et al. 
[3] , but contrary to those of Koss et al. [4] who ob- 
served a 75% increase in activity on lysis. Haemolysis 
of canine blood caused a considerable increase in the 
rate of adenosine inactivation: approximately 18-fold 
in the present experiments, as compared with &fold 
in those of Koss et al. [4] and lo-fold in those of 
Kiibler and Bretschneider [5]. The lower values re- 
ported for the earlier studies may have been due in 
part to incomplete lysis of the platelets (see below). 
4.2. Plasma 
The absolute level of adenosine deaminase activity 
in plasma was low for both species (table 2); as a per- 
2.34 0.40 
10.30 2.44 
0 4.87 
0 16.07 
- - 
- 
Human Canine 
1.09 17.7 
1.05 5.71 
- 12.5 
_ - 
centage of the total (intact) blood activity it was about 
1% in humans and about 14% in dogs (table 3). These 
results are in broad agreement with those of Koss et al. 
151. 
4.3. Elythrocytes and platelets 
It is generally assumed that the erythrocytes are 
largely responsible for the uptake of adenosine from 
both human and canine blood [3-71. However, table 
3 shows that in the present study canine erythrocytes 
accounted for only a small part of the adenosine in- 
activation potency of the blood, and even this small 
part may be questioned in view of the difficulty of 
ridding the erythrocytes completely of platelets. In- 
deed, in a subsidiary experiment using canine eryth- 
rocytes sedimented 3 times in Ficoll, we did not ob- 
serve any adenosine uptake by the cells or any ade- 
nosine deaminase activity on lysis. 
The platelet fractions of canine blood, intact or 
lysed, showed much the greatest activity (table 3). The 
higher potency of the intact platelet fraction than of 
the total blood sample may have been due to adsorption 
from solution of some of the adenosine in the latter, 
perhaps onto the erythrocytes. By contrast, for human 
blood, the platelet fraction had negligible activity, and 
over 90% of the total potency resided in the erythrocyte 
fraction. 
Further studies are in progress to investigate the 
differences in activity of the various blood fractions 
of other species. 
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